Laser-Profiled Continuum Robot with Integrated Tension Sensing
The Hamlyn Centre researchers proposed a laser-profiled continuum robot with integrated tension
sensing for simultaneous shape & tip force estimation.
Acceleron Announces Sotatercept Achieved Primary and Secondary Endpoints
Acceleron Announces Sotatercept Achieved Primary and Secondary Endpoints in the PULSAR Phase 2 Placebo-Controlled Trial in Patients.
COPD care and composite creations: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
Imperial researcher listed among top five most-cited scientists in the world
Imperial’s Professor Peter Barnes has been listed as one of the world’s most highly cited scientists in a list of 100,000 scientists across 22 fields.
2
Dog detectives sniff out harmful bacteria causing lung infections
Sniffer dogs have been trained to detect ultra-low concentrations of bacteria which cause lung infections in cystic fibrosis (CF) patients.
4
Emerging tech solutions to global AMR threat take centre stage at White City
Summit explores the role of emerging tech developments in optimising the use of antimicrobials, combatting AMR and supporting infection management.
Where have we got to in the fight against Cystic Fibrosis?
The recent European Cystic Fibrosis conference was a great showcase of the latest research and insights surrounding cystic fibrosis (CF).
Missing iron receptors predict lung disease patient’s poor outcome
Researchers discovered that a receptor vital to iron processing in the lungs is much less common in patients with idiopathic pulmonary fibrosis (IPF).
Hamlyn Symposium on Medical Robotics (23rd – 26th June 2019)
12th annual Hamlyn Symposium announcing key programme highlights plus Clinical Leaders’ Forum
Symposium sets new direction for infectious diseases research at Imperial
Infectious diseases experts shared their latest work at an annual research symposium hosted at Imperial’s Hammersmith Campus last month.
